Spacelabs Healthcare Partners with Masimo to Bring Advanced Measurements to Spacelabs Patient Monitors

Spacelabs Healthcare, a division of OSI Systems Inc., and Masimo announced that they have extended their partnership in patient monitoring to integrate SET pulse oximetry, NomoLine capnography, rainbow SET Pulse CO-Oximetry, SedLine brain function monitoring, and O3 regional oximetry into select Spacelabs multi-parameter monitors.

National Employer Groups to Hospitals and ASCs: Participate in the 2021 Leapfrog Surveys

Today, every hospital and ASC across the country received a letter signed by four influential national employer groups—the Health Transformation Alliance, ERISA Industry Committee, National Alliance of Health Care Purchaser Coalitions, and the Business Group on Health—requesting their participation in the annual Leapfrog Hospital Survey and Leapfrog Ambulatory Surgery Center (ASC) Survey.

Adapters to Test Light Cord Integrity

Healthmark Industries has introduced the Light Cord Adapters to its ProSys Instrument Care product line.

RSIP Vision Launches Advanced AI-Based Tool for Prostate MRI and Ultrasound Registration

RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, has announced a new prostate MRI-to-ultrasound registration tool.

Advanced Cooling Therapy Expands Team

Medical device firm Advanced Cooling Therapy (ACT) has expanded its team and achieved several strategic milestones in the commercial launch of its first product, the Esophageal Cooling Device (ECD).

Within less than 90 days of obtaining its de novo clearance from the FDA and manufacturing labeled product, the company has already had its first U.S. sales of the ECD, along with first human use in the country. A total of four clinical papers have now been published globally on the efficacy of the device.

To support the strong demand for the ECD, the company promoted Robin Drassler to Vice President of North American Sales, hired Maria Gray MA, RN, as Director for Clinical Services and added key sales managers to accommodate growth in the U.S. and globally.

The ECD is a temperature modulation device that is approved to use the esophageal environment for whole-body temperature modulation, including both cooling and warming. It’s designed to modulate and control patient temperature when clinically indicated through a single use, fully enclosed triple lumen system that is inserted into the esophagus. It received FDA de novo clearance in June of 2015, its CE Mark in Europe in 2014, and is licensed for sale in Canada and Australia. •



Submit a Comment

Your email address will not be published. Required fields are marked *